Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection
β Scribed by G. Taliani; P. Rucci; E. Biliotti; L. Cirrincione; A. Aghemo; A. Alberti; P. L. Almasio; D. Bartolozzi; N. Caporaso; R. Coppola; M. Chiaramonte; A. Floreani; G. B. Gaeta; M. Persico; G. Secchi; I. Versace; S. Zacharia; A. Mele
- Book ID
- 108886038
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 156 KB
- Volume
- 0
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This study assessed the effect of chronic hepatitis C virus (HCV) infection on the healthrelated quality of life (HRQOL) of injecting drug users, comparing the HRQOL of injecting drug users with and without chronic HCV infection. The study included 199 injecting drug users of more than 18 years of a
Previous Western studies showed a consistent and marked reduction in health-related quality of life (HRQOL) in patients chronically infected with hepatitis C virus (HCV). However, these studies were conducted on patients whose knowledge of their serological status may have affected their HRQOL. This
Eleven patients with chronic hepatitis D virus (HDV) infection who had chronic active hepatitis and HDV antigen on liver biopsy were randomised in a crossover therapeutic trial of interferon-alpha 2b vs. no therapy. Nine patients had a history of intravenous drug use (drug free > 6 months before the